Clinical Trial Update: A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase III trial of HMPL-004 in mild to moderate active ulcerative colitis was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• HMPL-004

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED | Results posted: 2020-01-02